Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
ClinicalTrials.gov study NCT02860000. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03776812. IPD Sharing: NO. Countries: 5. Publications: 2.
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02141438. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01848067. IPD Sharing: Not stated. Countries: 1. Publications: 52.
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03805594. IPD Sharing: NO. Countries: 1. Publications: 1.
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03072238. IPD Sharing: YES. Countries: 26. Publications: 3.
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT03406858. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00913835. IPD Sharing: YES. Countries: 1. Publications: 2.
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00988208. IPD Sharing: Not stated. Countries: 21. Publications: 3.
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04100018. IPD Sharing: Not stated. Countries: 28. Publications: 1.
Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer
ClinicalTrials.gov study NCT01053013. IPD Sharing: NO. Countries: 1. Publications: 6.
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02003924. IPD Sharing: YES. Countries: 32. Publications: 9.
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT01637402. IPD Sharing: NO. Countries: 1. Publications: 1.
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02502266. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.
ClinicalTrials.gov study NCT01193257. IPD Sharing: Not stated. Countries: 14. Publications: 3.
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00887198. IPD Sharing: Not stated. Countries: 11. Publications: 13.
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
ClinicalTrials.gov study NCT01732549. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
ClinicalTrials.gov study NCT00974311. IPD Sharing: Not stated. Countries: 15. Publications: 14.
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01543776. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02116582. IPD Sharing: YES. Countries: 5. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.